BSTC Insider Trading Activity and SEC Form 4 Filings
BSTC insider trading summary
No open-market insider purchases or sales of Biospecifics Technologies Corp (BSTC) have been reported on SEC Form 4 in the past 12 months.
Latest BSTC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 2, 2020 | Endo International plc | 10% Owner | Buy | $650.0M (7,344,955 @ $88.50) |
| Sep 10, 2019 | Toby Wegman | Director | Sell | $491K (8,900 @ $55.16) |
| Sep 9, 2019 | Toby Wegman | Director | Sell | $61K (1,100 @ $55.23) |
| Jun 7, 2019 | Jennifer M Chao | Director | Sell | $27K (459 @ $58.55) |
| Jun 5, 2019 | Jennifer M Chao | Director | Sell | $140K (2,411 @ $58.01) |
| Jun 5, 2019 | Jennifer M Chao | Director | Sell | $29K (500 @ $57.25) |
| Jun 4, 2019 | Jennifer M Chao | Director | Sell | $147K (2,600 @ $56.56) |
| Jun 3, 2019 | Patrick M Caldwell | Principal Financial Officer | Sell | $353K (6,000 @ $58.80) |
| May 29, 2019 | Jennifer M Chao | Director | Sell | $201K (3,313 @ $60.74) |
| May 24, 2019 | Mark N Wegman | Director | Sell | $477K (7,800 @ $61.09) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.